The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre

Blood Transfusion

Volumn 12, Issue 3, 2014, Pages 330-333

  Rerambiah, Leonard Kounegnigan ^a   Rerambiah, Laurence Essola ^b   Bengone, Calixte ^a   Siawaya, Joel F Djoba ^a,c  

^a National Blood Transfusion Centre (CNTS) National Public Health Laboratory (URDS LNSP)   (Gabon)

^b University Hospital Centre of Libreville (CHUL) National Public Health Laboratory (URDS LNSP)   (Gabon)

^c Specialised Diagnostics and Research Unit National Public Health Laboratory (URDS LNSP)   (Gabon)

Author keywords

HBV; HCV; HIV; Risk; Transfusion transmitted infections

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; PREVALENCE; SEROCONVERSION; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION; BLOODBORNE BACTERIUM; FEMALE; GABON; HEPACIVIRUS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; RISK FACTOR; TRANSMISSION;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; FEMALE; GABON; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS;

EID: 84904615687     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0144-13     Document Type: Article

References (28)

1. Stokx J, Gillet P, De Weggheleire A, et al. Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis 2011; 11: 141.
2. Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011; 2: 7-21.
3. Diarra A, Kouriba B, Baby M, et al. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol 2009; 16: 444-7.
4. Fouelifack Ymele F, Keugoung B, Fouedjio JH, et al. High rates of hepatitis B and C and HIV infections among blood donors in Cameroon: a proposed blood screening algorithm for blood donors in resource-limited settings. J Blood Transf 2012; 2012: 1-7.
5. Ampofo W, Nii-Trebi N, Ansah J, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol 2002; 40: 3523-5. (Pubitemid 34977485)
6. Gabon DGPS. Rapport National sur la réponse au VIH/SIDA. Libreville: Ministère de la Santé, 2012.
7. Dazza MC, Trebucq A, Gaudebout C, et al. Population-based study of serum hepatitis B virus DNA in Gabon. Trans R Soc Trop Med Hyg 1993; 87: 539-40.
8. Njouom R, Caron M, Besson G, et al. Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa. PLoS One 2012; 7: e42002.
9. Polizzotto MN, Wood EM, Ingham H, Keller AJ. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48: 55-63.
10. Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284 : 229-35. (Pubitemid 30460868)
11. World Health Organization. Screening donated blood for transfusion-transmissible infections: recommendations. Geneva: WHO Press; 2009.
12. Al Shaer L, Abdul Rahman M, John TJ, Al Hashimi A. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion 2012; 52: 2300-9.
13. Vrielink H, Reesink HW. Transfusion-transmissible infections. Curr Opin Hematol 1998; 5: 396-405. (Pubitemid 28521508)
14. Pomper GJ, Wu Y, Snyder EL. Risks of transfusion-transmitted infections: 2003. Curr Opin Hematol 2003; 10: 412-8. (Pubitemid 37352483)
15. Cable R, Lelie N, Bird A. Reduction of the risk of transfusion- transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Vox Sang 2013; 104: 93-9.
16. Stramer SL, Notari EP, Krysztof DE, Dodd RY. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Transfusion 2013; 53 (Suppl 3): 2449-58.
17. Laperche S. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013; 53: 816-26.
18. Tagny CT, Mbanya D, Leballais L, et al. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon. Transfusion 2011; 51: 184-90.
19. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-90. (Pubitemid 26193619)
20. Pillonel J, Laperche S. Trends in residual risk of transfusiontransmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing) [in French]. Transfus Clin Biol 2004; 11: 81-6. (Pubitemid 38561185)
21. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721-9. (Pubitemid 36629116)
22. Chiavetta JA, Escobar M, Newman A, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003; 169: 767-73. (Pubitemid 37305113)
23. Dodd RY, Notari EPt, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-9.
24. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002; 117: 215-9. (Pubitemid 34304446)
25. Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis 2012; 12: 160.
26. Dodd RY. Current safety of the blood supply in the United States. Int J Hematol 2004; 80: 301-5. (Pubitemid 39564628)
27. Lefrère JJ, Dahourouh H, Dokekias AE, et al. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011; 51: 486-92.
28. Jayaraman S, Chalabi Z, Perel P, et al. The risk of transfusion- transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 433-42.